Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for daytime sleepiness and driving performance in obese adults with type 2 diabetes without sleep apnea
2008-008141-37Phase 4Unknown
- Sponsor
- Sherwood Forest Hospitals NHS Foundation Trust
- Start
- Jul 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Sherwood Forest Hospitals NHS Foundation Trust. Primary endpoint: Wakefulness and vigilance. Status: unknown.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-008141-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008141-37.